This profile is being populated. Some content may not yet be available. See Medicine for additional information.
Publications
2 publications
Funding
1 grant
Completed grants (1)
- Sub-PIUF 232202-01Real world experience on the use of ceftolozane-tazobactam in the treatment of Gram-negative bacteremia - a multicentric experience from the United StatesMerck Sharp & Dohme LLC · 2022–2025 · via University of Florida
Clinical research
1 study
Completed & closed trials (1)
- PISPIND 173509 ClofazimineNovartis Pharmaceuticals Corporation · CLOSED TO ACCRUAL (as of 2024)